Dr. Maurizio Fava

NSI-189 Scientific Advisors

Harvard, MGH, Executive Vice Chair, Dept. of Psychiatry Principal Investigator: NSI-189 Phase 2 MDD clinical trial

Dr. Michael Thase

NSI-189 Scientific Advisors

Univ. of Pennsylvania, Chief. Division of Mood and Anxiety Disorders Treatment and Research Program

Dr. Mark Frye

NSI-189 Scientific Advisors

Mayo Clinic, Chair, Psychiatry and Psychology

Dr. John Greden

NSI-189 Scientific Advisors

Univ. of Michigan, Founder and Executive Director, Healthy System Depression Center

Dr. Richard Keefe

NSI-189 Scientific Advisors

Duke Institute for Brain Sciences, Director Schizophrenia Research Group

Dr. Thomas Laughren

NSI-189 Scientific Advisors

Harvard, MGH, Director, Regulatory Affairs, Former Director of Psychiatric Division, CDER, FDA

Dr. Roger McIntyre

NSI-189 Scientific Advisors

Dr. Kate Burdick

NSI-189 Scientific Advisors